184 related articles for article (PubMed ID: 22854605)
1. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
[TBL] [Abstract][Full Text] [Related]
2. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
Bond AJ; Reed KD; Beavan P; Strang J
Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
[TBL] [Abstract][Full Text] [Related]
3. Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients.
Walter M; Wiesbeck GA; Degen B; Albrich J; Oppel M; Schulz A; Schächinger H; Dürsteler-MacFarland KM
Addict Biol; 2011 Jan; 16(1):145-51. PubMed ID: 20331562
[TBL] [Abstract][Full Text] [Related]
4. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
Falcato L; Beck T; Reimer J; Verthein U
J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
6. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
7. The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence.
Gerber H; Borgwardt SJ; Schmid O; Gerhard U; Joechle W; Riecher-Rössler A; Wiesbeck GA; Walter M
Eur Addict Res; 2012; 18(3):116-23. PubMed ID: 22286020
[TBL] [Abstract][Full Text] [Related]
8. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy.
Eder H; Jagsch R; Kraigher D; Primorac A; Ebner N; Fischer G
Addiction; 2005 Aug; 100(8):1101-9. PubMed ID: 16042640
[TBL] [Abstract][Full Text] [Related]
11. Diacetylmorphine versus methadone for the treatment of opioid addiction.
Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
[TBL] [Abstract][Full Text] [Related]
12. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
[TBL] [Abstract][Full Text] [Related]
13. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
14. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.
Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K
Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270
[TBL] [Abstract][Full Text] [Related]
15. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
[TBL] [Abstract][Full Text] [Related]
16. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
17. [Initial results with withdrawal treatments of male and female participants in the diversified Janus opiate prescription project in Basel].
Stohler R; Hug I; Knoll B; Mohler B; Ladewig D
Praxis (Bern 1994); 1996 Nov; 85(48):1537-41. PubMed ID: 8992565
[TBL] [Abstract][Full Text] [Related]
18. Tetrodotoxin alleviates acute heroin withdrawal syndrome: a multicentre, randomized, double-blind, placebo-controlled study.
Song H; Li J; Lu CL; Kang L; Xie L; Zhang YY; Zhou XB; Zhong S
Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):510-4. PubMed ID: 21575032
[TBL] [Abstract][Full Text] [Related]
19. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
20. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]